[Ip-health] Kumar, former Obama trade offical, now with Sanofi
Michael H Davis
m.davis at csuohio.edu
Wed Jun 3 08:24:35 PDT 2015
I particularly like mention of the "health care industry." These people have no shame, of course, but the tin ears that are totally deaf to
the common good is just beyond shocking.
Prof. Mickey Davis
Cleveland State University
2121 Euclid Avenue, LB 234
Cleveland, OH 44115-2214
Cleveland-Marshall College of Law
1801 Euclid Avenue
Law Building, LB 234
50 Avenue A
NYC, N.Y. 10009
Admitted to practice before the United States Patent and Trademark Office, Reg. No. 45,863
-------- Original message --------
From: Jamie Love <james.love at keionline.org>
Date: 06/03/2015 8:48 AM (GMT-05:00)
To: Ip-health <ip-health at lists.keionline.org>
Subject: [Ip-health] Kumar, former Obama trade offical, now with Sanofi
Another revolving door story.
* In 2010, the United States Senate unanimously confirmed Mr. Kumar as
Assistant Secretary of Commerce and Director General of the U.S. and
Foreign Commercial Service where he spearheaded global trade for the Obama
SANOFI APPOINTS SURESH KUMAR TO THE EXECUTIVE COMMITTEE AND EXECUTIVE VICE
PRESIDENT, EXTERNAL AFFAIRS
PRESS KITS ARE INTENDED FOR JOURNALISTS FOR A PROFESSIONAL USE.
May 26, 2015
Sanofi Appoints Suresh Kumar to the Executive Committee and Executive Vice
President, External Affairs
Paris, France - May 26, 2015 - Sanofi today announced the appointment of
Suresh Kumar as a new member of the Executive Committee, effective June 1,
2015. Mr. Kumar joins Sanofi from Oliver Wyman and will take the position
of Executive Vice President, External Affairs.
In this newly created role, Mr. Kumar will be responsible for defining
Sanofi's vision for meeting global health challenges. This will include
setting the strategy and priorities for public affairs activities,
interactions with governments and international organizations - and
aligning internal and external communications around these priorities. As
part of bringing these activities together in a more integrated way, the
Communications and Corporate Social Responsibility teams will report to Mr.
"Suresh brings a genuinely unique profile to Sanofi that includes a
diversified, international career within the healthcare industry, public
sector leadership experience and an intimate understanding of NGOs," said
Olivier Brandicourt, CEO, Sanofi. "Suresh's deep relationships with
business and government leaders worldwide and his passion for making an
impact on improving lives through healthcare will make Suresh a valuable
addition to Sanofi and the Executive Committee."
About Suresh Kumar
A U.S. citizen, born and educated in India, Mr. Kumar has more than 30
years of experience in the healthcare industry beginning in 1978 in India
with Johnson and Johnson. At Warner Lambert from 1989 to 1999, he held
increasingly senior roles in consumer healthcare in Canada, North America,
Latin America and Asia. Mr. Kumar again joined Johnson & Johnson in 1999 as
a Member of the Group Operating Committee and International Vice President
of the Worldwide Consumer Pharmaceuticals business.
In 2006, Mr. Kumar joined the Clinton Foundation as Special Advisor focused
on Sub-Saharan Africa, where he created programs focused on enhancing lives
through improved agricultural performance and food security. In 2010, the
United States Senate unanimously confirmed Mr. Kumar as Assistant Secretary
of Commerce and Director General of the U.S. and Foreign Commercial Service
where he spearheaded global trade for the Obama Administration. Since 2013,
Mr. Kumar has served as a Partner with Oliver Wyman leading the firm's
Public Sector Practice and as part of the Health and Life Sciences Team.
Mr. Kumar has an Economics degree from Delhi University, a Masters in
Management from Bombay University.
Sanofi, a global healthcare leader, discovers, develops and distributes
therapeutic solutions focused on patients' needs. Sanofi has core strengths
in the field of healthcare with seven growth platforms: diabetes solutions,
human vaccines, innovative drugs, consumer healthcare, emerging markets,
animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT:
SAN) and in New York (NYSE: SNY).
Tel. : +33 (0)1 53 77 46 46
mr at sanofi.com Investor Relations
Tel.: +33 (0)1 53 77 45 45
ir at sanofi.com
James Love. Knowledge Ecology International
KEI DC tel: +1.202.332.2670, US Mobile: +1.202.361.3040, Geneva Mobile:
Ip-health mailing list
Ip-health at lists.keionline.org
More information about the Ip-health